Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
ANNX Annexon
- 3.070
- +0.060+1.99%
Close Feb 14 16:00 ET
- 3.080
- +0.010+0.33%
Post 18:45 ET
327.24MMarket Cap-2.98P/E (TTM)
3.240High3.000Low851.36KVolume3.030Open3.010Pre Close2.63MTurnover1.21%Turnover RatioLossP/E (Static)106.59MShares8.40052wk High0.99P/B216.23MFloat Cap2.87052wk Low--Dividend TTM70.43MShs Float38.010Historical High--Div YieldTTM7.97%Amplitude1.570Historical Low3.086Avg Price1Lot Size
About Annexon Company
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.
Company Profile
SymbolANNX
Company NameAnnexon
Listing DateJul 24, 2020
Issue Price17.00
Founded2011
CEOMr. Douglas Love, Esq.
MarketNASDAQ
Employees71
Fiscal Year Ends12-31
Address1400 Sierra Point Parkway,Building C,Suite 200
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Phone1-650-822-5500
Websitehttp://www.annexonbio.com
Company Executives
- Name
- Position
- Salary
- Douglas Love, Esq.
- President, Chief Executive Officer and Director
- 2.45M
- Dr. Jamie Dananberg, M.D.
- Executive Vice President and Chief Medical Officer
- --
- Jennifer Lew
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Ted Yednock,PhD
- Executive Vice President and Chief Innovation Officer
- 1.14M
- Michael Overdorf
- Executive Vice President and Chief Business Officer
- --
- Dr. Dean Richard Artis, PhD
- Executive Vice President and Chief Scientific Officer
- 1.83M
- Thomas G. Wiggans
- Chairman of the Board
- 132.43K
- William B.J. Jones, Jr
- Director
- --
- William D. Waddill
- Independent Director
- 103.43K
- Bettina M. Cockroft
- Independent Director
- 100.93K
- Jung E. Choi
- Independent Director
- 100.93K
- Muneer A. Satter
- Independent Director
- 103.93K
- Dr. William H. Carson, M.D.
- Independent Director
- 103.43K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.